| RS2148427910 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148428124 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148428193 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148428322 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2148428395 |
DMD
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Dystrophin deficiency |
| RS2148429508 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2148434034 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148434107 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS2148436383 |
ATRX
|
Health Risk |
Likely pathogenic |
— |
| RS2148442883 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148443048 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148443341 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2148443351 |
ALK
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS2148443574 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2148443715 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148446020 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS2148446128 |
STAG2
|
Health Risk |
Likely pathogenic |
— |
| RS2148450759 |
SSR4
|
Health Risk |
Pathogenic |
SSR4-congenital disorder of glycosylation, SSR4-congenital disorder of glycosylation |
| RS2148450972 |
SSR4
|
Health Risk |
Pathogenic |
SSR4-congenital disorder of glycosylation, SSR4-congenital disorder of glycosylation |
| RS2148451946 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2148455901 |
MTM1
|
Health Risk |
Likely pathogenic |
— |
| RS2148456062 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148456078 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148456401 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148456625 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148456690 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Squamous cell carcinoma of the head and neck |
| RS2148456727 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148457026 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148457196 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148457829 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS2148458912 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148459016 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148459355 |
DYM
|
Health Risk |
Likely pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2148459492 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148459928 |
DMD
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2148460005 |
DMD
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Elevated circulating creatine kinase concentration |
| RS2148460313 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148460570 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148460867 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148461695 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148463710 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2148463805 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2148463846 |
CHRDL1
|
Health Risk |
Pathogenic |
Megalocornea, Megalocornea |
| RS2148464034 |
NBAS
|
Health Risk |
Likely pathogenic |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS2148464837 |
IFT172
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS2148465558 |
CHRDL1
|
Health Risk |
Likely pathogenic |
Megalocornea, Megalocornea |
| RS2148467030 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS2148467424 |
IFT172
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS2148467517 |
IFT172
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS2148468809 |
TOR1AIP1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS2148468818 |
TOR1AIP1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS2148468861 |
TOR1AIP1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS2148472644 |
IFT172
|
Health Risk |
Likely pathogenic |
IFT172-related disorder, IFT172-related disorder |
| RS2148474921 |
ITGB4
|
Health Risk |
Pathogenic |
— |
| RS2148476381 |
IFT172
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 20, Bardet-Biedl syndrome 20 |
| RS2148477195 |
IFT172
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS2148477695 |
IFT172
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS2148479160 |
IFT172
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS2148479895 |
TAF1
|
Health Risk |
association |
Heart, malformation of |
| RS2148480016 |
TOR1AIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS2148484887 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148485071 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148485357 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148485378 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148485744 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148485970 |
IFT172
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS2148486874 |
IFT172
|
Health Risk |
Pathogenic |
— |
| RS2148487077 |
IFT172
|
Health Risk |
Pathogenic |
— |
| RS2148488085 |
TAF1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2148488146 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2148488251 |
TAF1
|
Health Risk |
Pathogenic |
Heart, malformation of |
| RS2148488364 |
MTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148488410 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148488487 |
MTM1
|
Health Risk |
Likely pathogenic |
— |
| RS2148488506 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148491730 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148491960 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
L1CAM-related disorder, L1 syndrome |
| RS2148492200 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148492410 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
MASA syndrome, Spastic paraplegia |
| RS2148493243 |
L1CAM
|
Health Risk |
Pathogenic |
MASA syndrome, Thyroid cancer |
| RS2148493304 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2148493825 |
L1CAM
|
Health Risk |
Pathogenic |
Global developmental delay, Spastic paraplegia |
| RS2148493879 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148493891 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148494055 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148494096 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148494123 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS2148494128 |
L1CAM
|
Health Risk |
Pathogenic/Likely pathogenic |
MASA syndrome, X-linked hydrocephalus syndrome |
| RS2148494337 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148495027 |
L1CAM
|
Health Risk |
Likely pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS2148495720 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2148495739 |
L1CAM
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148496033 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2148496168 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS2148496455 |
L1CAM
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2148496532 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2148496739 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS2148497420 |
CC2D2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 93, Retinitis pigmentosa 93 |
| RS2148497631 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS2148497891 |
MTM1
|
Health Risk |
Likely pathogenic |
— |